FC

Felix Cleemann

AA Ascendis Pharma Growth Disorders A/S: 9 patents #3 of 14Top 25%
AA Ascendis Pharma Bone Diseases A/S: 7 patents #2 of 12Top 20%
SA Sanofi-Aventis: 4 patents #303 of 1,008Top 35%
AA Ascendis Pharma A/S: 2 patents #25 of 38Top 70%
Overall (All Time): #187,926 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12403182 Liquid pharmaceutical formulations of PTH conjugates Anja R. H. Skands, Michael Duelund Sørensen, Julia Baron, Eric Hoffmann, Kennett Sprogøe 2025-09-02
12239689 Controlled-release CNP agonists with low initial NPR-B activity Kennett Sprogøe, Harald Rau, Ulrich Hersel 2025-03-04
12214020 PTH prodrugs Kennett Sprogøe, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler 2025-02-04
12156917 CNP prodrugs with carrier attachment at the ring moiety Harald Rau, Ulrich Hersel, Kennett Sprogøe 2024-12-03
12083182 Controlled-release CNP agonists with increased NEP stability Kennett Sprogøe, Harald Rau, Ulrich Hersel 2024-09-10
11918628 Controlled-release PTH compound Kennett Sprogøe, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler 2024-03-05
11890326 Controlled-release PTH compound Kennett Sprogøe, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler 2024-02-06
11857603 PTH compounds with low peak-to-trough ratios Kennett Sprogøe, Lars Holten-Andersen, David Karpf, Guillaume Maitro, Mathias Krusch +2 more 2024-01-02
11793861 PTH prodrugs Kennett Sprogøe, Guillaume Maitro, Mathias Krusch, Thomas Wegge, Joachim Zettler 2023-10-24
11759504 PTH compounds with low peak-to-trough ratios Kennett Sprogøe, Lars Holten-Andersen, David Karpf, Guillaume Maitro, Mathias Krusch +2 more 2023-09-19
11633487 Prodrugs comprising an aminoalkyl glycine linker Nicola Bisek, Harald Rau, Thomas Knappe, Romy Reimann 2023-04-25
11413351 CNP prodrugs with carrier attachment at the ring moiety Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2022-08-16
11389510 Controlled-release CNP agonists with low initial NPR-B activity Kennett Sprogøe, Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2022-07-19
11389511 Controlled-release CNP agonists with reduced side-effects Kennett Sprogøe, Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2022-07-19
11311604 Controlled-release CNP agonists with low NPR-C binding Harald Rau, Ulrich Hersel, Kennett Sprogøe, Frank Faltinger, Thomas Wegge 2022-04-26
11154593 CNP prodrugs with large carrier moieties Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2021-10-26
10835578 CNP prodrugs with large carrier moieties Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2020-11-17
9457066 Prodrugs comprising an insulin linker conjugate Harald Rau, Ulrich Hersel, Silvia Kaden-Vagt, Torben Lessmann, Thomas Wegge 2016-10-04
9265723 Long acting insulin composition Kennett Sprogoe, Ulrich Hersel, Silvia Kaden-Vagt, Torben Lessmann, Harald Rau +1 more 2016-02-23
9138462 Prodrugs comprising an insulin linker conjugate Harald Rau, Ulrich Hersel, Silvia Kaden-Vagt, Torben Lessman, Thomas Wegge 2015-09-22
9133276 Prodrugs comprising an exendin linker conjugate Ulrich Hersel, Torben Lessman, Harald Rau 2015-09-15
8906847 Prodrug comprising a drug linker conjugate Ulrich Hersel, Silvia Kaden, Harald Rau, Thomas Wegge 2014-12-09